Antimicrobial resistance (AMR) is a growing global health threat, driven by the misuse and overuse of antibiotics across human health, animal health, and agriculture. AntiBacter research group is committed to contribute in combating the local and global AMR challenge by working on a diverse range of research projects that are directly/indirectly focusing human and animal infections. Our group is investigating antibacterial strategies like Phage therapy, antimicrobial compounds, quorum quenching (QQ), the synthetic RNA and CRISPR-based approaches to control MDR infections. AMR is one of the major focused areas of One Health approaches, and therefore AntiBacter is committed to investigate various bacterial infections with proven/unproven zoonotic potential like bovine mastitis, avian colibacillosis, and ESKAPE pathogens from hospitals and environment. Antibacter is open to all researchers who wish to collaborate for working together to tackle the challenge of AMR.